Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Smithtown › NPI 1982663423
Hospital

ST. Catherine of Siena Medical Center

ST. Catherine of Siena Medical Center was paid $10.97M by Medicaid between Jan 2018 and Dec 2024, across 130 billing codes. Its largest line is H2019, therapeutic behavioral services, billed per 15 minutes — 38% of everything it billed.

33Billing provider infoST. CATHERINE OF SIENA MEDICAL CENTER
SMITHTOWN, NY 11787
33aNPI1982663423assigned 03/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.97M
24GClaims172,565
24DCodes billed130
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#79 of 231
Median peer was paid$561K
This provider vs. median20×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,343$38K
20199,063$254K
202022,511$797K
202134,005$2.30M
202235,482$2.94M
202340,671$2.73M
2024incomplete29,490$1.91M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
H2019 Therapeutic behavioral services, billed per 15 minutesTherapeutic behavioral services, per 15 minutes 38% 4,627 4,616 $4.18M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.2% 4,269 4,112 $680K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.1% 4,304 4,165 $665K
G0378 Hospital observation service, per hour 6.0% 1,665 1,610 $655K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 5.6% 1,799 1,796 $618K
96361 Intravenous infusion, hydration; each additional hour 5.4% 2,976 2,607 $598K
H2018 Psychosocial rehabilitation services, per diem 4.9% 1,026 1,024 $536K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.8% 2,779 2,673 $418K
70450 Computed tomography, head or brain; without contrast material 2.7% 1,319 1,276 $294K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.2% 1,103 1,078 $244K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 1,302 1,261 $211K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.8% 330 328 $195K
118 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.6% 2,475 $180K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 1,706 $179K
80053 Comprehensive metabolic panel 1.5% 9,879 $165K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.2% 813 $127K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.1% 168 $121K
93975 <1% 252 $87K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 338 $77K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,595 $69K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,422 $57K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,599 $55K
36415 Collection of venous blood by venipuncture <1% 12,998 $54K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,155 $40K
J3490 Unclassified drugs <1% 986 $39K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 959 $32K
80048 Basic metabolic panel (calcium, ionized) <1% 1,806 $28K
86850 <1% 1,829 $27K
86901 <1% 1,831 $23K
86900 <1% 1,836 $23K
83880 <1% 910 $23K
85610 <1% 6,194 $20K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 48 $20K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 40 $20K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 115 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,279 $13K
95806 <1% 77 $12K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 160 $12K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 5,475 $11K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 140 $11K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 44 $10K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 8,849 $9K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 29 $9K
80061 Lipid panel <1% 1,080 $9K
85730 <1% 5,705 $7K
81025 <1% 2,628 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 303 $6K
84702 <1% 1,857 $6K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,632 $6K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 28 $5K
87631 <1% 129 $5K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 13 $4K
80050 General health panel <1% 156 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 1,721 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,690 $4K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 23 $3K
76000 <1% 32 $3K
87088 <1% 3,260 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,629 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 949 $3K
59025 Fetal non-stress test <1% 14 $2K
84443 Thyroid stimulating hormone (TSH) <1% 1,181 $2K
82947 <1% 3,966 $2K
80076 <1% 151 $1K
85027 <1% 1,844 $1K
71046 Radiologic examination, chest; 2 views <1% 313 $1K
83735 <1% 4,764 $1K
83605 <1% 1,530 $1K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,963 $1K
71045 Radiologic examination, chest; single view <1% 2,987 $1K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,095 $1K
81003 <1% 4,137 $983.47
88304 <1% 126 $945.06
72125 Computed tomography, cervical spine; without contrast material <1% 12 $724.49
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 29 $665.72
84100 <1% 3,259 $543.55
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 12 $526.16
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,008 $478.61
96376 <1% 79 $469.85
J1170 Injection, hydromorphone, up to 4 mg <1% 348 $401.21
88342 <1% 14 $380.08
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 12 $344.61
84439 <1% 51 $292.11
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 989 $288.14
83690 <1% 1,819 $284.04
J2704 Injection, propofol, 10 mg <1% 1,805 $245.95
82728 <1% 126 $243.54
87040 <1% 1,917 $243.26
84484 <1% 3,101 $228.26
C1889 Implantable/insertable device, not otherwise classified <1% 25 $223.54
86141 <1% 316 $217.61
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 750 $194.01
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 168 $187.77
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,541 $183.30
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 14 $177.43
86803 <1% 25 $175.53
87581 <1% 12 $172.26
87486 <1% 12 $172.26
85379 <1% 583 $146.54
82550 <1% 624 $136.42
J0690 Injection, cefazolin sodium, 500 mg <1% 531 $113.90
J7120 Ringers lactate infusion, up to 1000 cc <1% 175 $93.36
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,430 $69.22
82077 <1% 944 $63.37
S0028 Injection, famotidine, 20 mg <1% 165 $61.74
J1741 Injection, ibuprofen, 100 mg <1% 38 $50.40
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 173 $45.80
80143 <1% 637 $36.88
80179 <1% 610 $33.88
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 324 $29.00
84145 <1% 310 $25.23
73630 <1% 14 $25.00
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,092 $23.66
J7050 Infusion, normal saline solution, 250 cc <1% 163 $17.54
87077 <1% 28 $16.16
J1644 Injection, heparin sodium, per 1000 units <1% 300 $13.51
84436 <1% 13 $11.26
85007 <1% 44 $9.31
87070 <1% 80 $8.15
87186 <1% 27 $6.59
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 58 $1.13
J1171 Injection, hydromorphone, 0.1 mg <1% 28 $0.90
J2270 Injection, morphine sulfate, up to 10 mg <1% 194 $0.36
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 14 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 17 $0.00
87276 0% 18 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 19 $0.00
84703 0% 13 $0.00
87275 0% 18 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 25 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPOHLMAN, JOHN (VP OF FINANCE)